Latest article
U.S. FDA declines to approve Provention Bio’s diabetes drug
(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
BeatO launches Flash Glucose Monitoring programme for diabetes prevention, management and reversal
Read the article The Flash Glucose Monitoring (FGM) -based program enables BeatO members to gain...
